Document is current
Any future updates will be listed below
-
Authors
Hill, Anita
DeZern, Amy E.
Kinoshita, Taroh
Brodsky, Robert A.
- License Information
-
More Information
Article History
First Online: 18 May 2017
Competing interests
: A.H. has received honoraria from and consulted for Akari Therapeutics, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Ra Pharmaceuticals and Roche. T.K. has received honoraria and speakers fees from and consulted for Alexion Pharmaceuticals. R.A.B is on the scientific advisory boards of Alexion Pharmaceuticals, Apellis Pharmaceuticals and Achillion Pharmaceuticals; R.A.B. also receives grant funding from Alexion. A.E.D. declares no competing interests.
